Universidad Peruana Cayetano Heredia

ListarArtículos en revistas indizadas por tema "Systemic lupus erythematosus"

ListarArtículos en revistas indizadas por tema "Systemic lupus erythematosus"

Ordenar por:Orden:Resultados:

  • Ugarte Gil, Manuel Francisco; Gamboa-Cárdenas, Rocio V.; Reátegui-Sokolova, Cristina; Medina-Chinchón, Mariela; Zevallos, Francisco; Elera-Fitzcarrald, Claudia; Pimentel Quiroz, Víctor Roman; Cucho-Venegas, Jorge M.; Rodríguez-Bellido, Zoila; Pastor-Asurza, Cesar A.; Alarcón, Graciela S.; Perich-Campos, Risto (Wiley, 2019)
    Objective: To determine if low disease activity state (LDAS)/remission predicts a better health‐related quality of life (HRQoL). Methods: Patients with systemic lupus erythematosus from a single center and having completed ...
  • Porta, S.V.; Ugarte Gil, Manuel Francisco; Garciá-De La Torre, I.; Bonfá, E.; Gómez-Puerta, J.A.; Arnaud, L.; Cardiel, M.H.; Alarcón, Graciela S.; Pons-Estel, B.A.; Pons-Estel, G. (Wolters Kluwer Health, 2022)
    Systemic lupus erythematosus (SLE) is characterized by great clinical heterogeneity. The objectives of its management are to make a timely diagnosis and to initiate treatment as promptly as possible so organ damage can be ...
  • Porta, Sabrina Valeria; Ugarte Gil, Manuel Francisco; García-de la Torre, Ignacio; Bonfá, Eloísa; Gómez-Puerta, José A.; Arnaud, Laurent; Cardiel, Mario H.; Alarcón, Graciela S.; Pons-Estel, Bernardo A.; Pons-Estel, Guillermo (Wolters Kluwer Health, 2022)
    Systemic lupus erythematosus (SLE) is characterized by great clinical heterogeneity. The objectives of its management are to make a timely diagnosis and to initiate treatment as promptly as possible so organ damage can ...
  • Pons-Estel, Guillermo J.; Ugarte Gil, Manuel Francisco; Alarcón, Graciela S. (Taylor and Francis, 2017)
    INTRODUCTION: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which occurs in both genders, and across racial/ethnic and age groups; however, higher rates are observed in adults, in women and in ...
  • Elera-Fitzcarrald, Claudia; Fuentes, Alejandro; González, Luis Alonso; Burgos, Paula I.; Alarcón, Graciela S.; Ugarte Gil, Manuel Francisco (Taylor and Francis, 2018)
    INTRODUCTION: Patients with systemic lupus erythematosus (SLE) have a better survival than decades ago; nevertheless, they still experience a low health-related (HR) quality of life (QoL). Areas covered: After defining QoL ...
  • Barile-Fabris, Leonor A.; Fragoso-Loyo, Hilda; Wojdyla, Daniel; Quintana, Rosana; Pons-Estel, Guillermo J.; Catoggio, Luis J.; Garcia, Mercedes A.; Saurit, Veronica; Drenkard, Cristina; Bonfa, Eloisa; Borba, Eduardo F.; Sato, Emilia; Tavares-Brenol, Joao C.; Cavalcanti, Fernando; Da Silva, Nilzio A.; Lavras-Costallat, Lilian T.; Guibert-Toledano, Marlene; Massardo, Loreto; Neira, Oscar; Cardiel, Mario H.; Amigo, Mary Carmen; Garcia-De-La-Torre, Ignacio; Silveira, Luis H.; Acevedo-Vasquez, Eduardo M.; Chacón-Díaz, Rosa; Esteva-Spinetti, María H.; Alarcón, Graciela S.; Pons-Estel, Bernardo A. (SAGE Publications, 2021)
    INTRODUCTION: Factors related to presentation of neuropsychiatric (NP) SLE manifestations, early in the course of the disease, and during follow up have not been clearly established. PURPOSE: To identify disease and ...
  • Pimentel Quiroz, Víctor Roman; Ugarte Gil, Manuel Francisco; Harvey, G. B.; Wojdyla, D.; Pons-Estel, G. J.; Quintana, R.; Esposto, A.; Garcia, M. A.; Catoggio, L. J.; Cardiel, M. H.; Barile, L. A.; Amigo, M.-C.; Sato, E. I.; Bonfa, E.; Borba, E.; Lavras Costallat, L. T.; Neira, O. J.; Massardo, L.; Guibert-Toledano, M.; Chacon-Diaz, R.; Alarcón, Graciela S.; Pons-Estel, B. A. (SAGE Publications, 2019)
    AIM: The aim of this study was to identify factors predictive of serious infections over time in patients with systemic lupus erythematosus (SLE). METHODS: A multi-ethnic, multi-national Latin American SLE cohort was ...
  • Tejada-Llacsa, Paul J.; Villacorta-Landeo, Pamela; Aguilar-Buitrón, Eder; Alarcón, Graciela S.; Ugarte Gil, Manuel Francisco (SAGE Publications, 2021)
    BACKGROUND/OBJECTIVE: Information available on the internet about Systemic Lupus Erythematosus (SLE) can influence the doctor-patient relationship. Therefore, the aim of this study was to identify the terms used for SLE ...
  • Quintana, Rosana; Pons-Estel, Guillermo; Roberts, Karen; Sacnun, Monica; Berbotto, Guillermo; Garcia, Mercedes A.; Saurit, Veronica; Barile-Fabris, Leonor; Acevedo-Vazquez, Eduardo M.; Tavares Brenol, Joao C.; Sato, Emilia I.; Iglesias, Antonio; Uribe, Oscar; Alarcón, Graciela S.; Pons-Estel, Bernardo A. (BMJ Publishing Group, 2019)
    Objective: To compare the clinical, laboratory and outcome features of SLE patients with and without Jaccoud's arthropathy (JA) from the Grupo Latino Americano De Estudio del Lupus (GLADEL) cohort. Methods: 1480 patients ...
  • Ugarte Gil, Manuel Francisco; Gonzalez, L. A.; Alarcón, Graciela S. (SAGE Publications, 2019)
    Is systemic lupus erythematosus (SLE) is occurring more frequently now than in decades past? Despite improvements in the identification of patients with SLE, the development of new classification criteria, and the recognition ...
  • Gonzalez, LA; Alarcon, Graciela S.; Harvey, GB; Quintana, R; Pons-Estel, GJ; Ugarte-Gil, MF; Vasquez, G; Catoggio, LJ; Garcia, MA; Borba, EF; GLADEL Grp Latino Amer (BMJ Group, 2023)
    Background: Systemic lupus erythematosus (SLE) is an important cause of secondary warm-antibody autoimmune hemolytic anemia (AIHA). The prevalence of AIHA has been estimated to range from 5% to 30%, but severe AIHA is ...
  • González, Luis Alonso; Santamaría-Alza, Yeison; Alarcón, Graciela S. (Elsevier, 2021)
    Damage reflects the irreversible changes that occur in systemic lupus erythematosus (SLE) patients as a consequence of the disease, its treatment or comorbidities. The pattern of damage increases in a steady linear fashion ...
  • González, L.A.; Alarcón, Graciela S.; Harvey, G.B.; Quintana, R.; Pons-Estel, G.J.; Ugarte-Gil, M.F.; Vásquez, G.; Catoggio, L.J.; García, M.A.; Borba, E.F.; Da Silva, N.A.; Tavares Brenol, J.C.; Toledano, M.G.; Massardo, L.; Neira, O.; Pascual-Ramos, V.; Amigo, M.-C.; Barile-Fabris, L.A.; De La Torre, I.G.; Alfaro-Lozano, J.; Segami, M.I.; Chacón-Díaz, R.; Esteva-Spinetti, M.H.; Iglesias-Gamarra, A.; Pons-Estel, B.A. (SAGE Publications, 2023)
    Objective: To determine the predictors of the occurrence of severe autoimmune hemolytic anemia (AIHA) and its impact on damage accrual and mortality in SLE patients. Methods: Factors associated with time to severe AIHA ...
  • Perea-Seoane, Luciana; Agapito-Vera, Estefania; Gamboa-Cardenas, Rocío V.; Guzmán-Sánchez, Geny; Pimentel Quiroz, Víctor Roman; Reategui-Sokolova, Cristina; Medina, Mariela; Elera-Fitzcarrald, Claudia; Noriega, Erika; Rodriguez-Bellido, Zoila; Pastor-Asurza, Cesar; Perich-Campos, Risto; Alarcón, Graciela S.; Ugarte Gil, Manuel Francisco (SAGE Publications, 2022)
    Objective: To assess whether the care model (comprehensive vs regular) has any impact on the clinical outcomes of systemic lupus erythematosus patients. Methods: Between August 2019 and January 2020, we evaluated SLE ...
  • Duarte-Garcia, A; Hocaoglu, M; Valenzuela-Almada, M; Osei-Onomah, SA; Dabit, JY; Sanchez-Rodriguez, A; Duong, SQ; Giblon, RE; Langenfeld, HE; Alarcón, Graciela S.; Helmick, CG; Crowson, CS (BMJ Publishing Group, 2022)
    Objectives: To determine the trends in incidence, prevalence and mortality of systemic lupus erythematosus (SLE) in a US population over four decades. Methods: We identified all the patients with SLE in Olmsted County, ...
  • Zavala Flores, Ernesto Moises; Salcedo-Matienzo, J.; Quiroz-Alva, A.; Berrocal-Kasay, A. (Springer, 2022)
    The objective of this study is to identify post SARS-CoV-2 vaccine BNT162b2 (BioNTech & Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano Heredia Hospital, Lima, Peru. A descriptive ...
  • Ugarte Gil, Manuel Francisco; Alarcón, Graciela S. (Springer, 2014)
    Despite significant advances in our understanding of the pathogenesis of systemic lupus erythematosus (SLE), there are only a few drugs approved by the regulatory agencies across the world for the treatment of these patients; ...
  • González, Luis Alonso; Ugarte Gil, Manuel Francisco; Alarcón, Graciela S. (SAGE Publications, 2020)
    During the last decades, there has been an increased interest in the discovery and validation of biomarkers that reliably reflect specific aspects of lupus. Although many biomarkers have been developed, few of them have ...
  • Ugarte Gil, Manuel Francisco; Burgos, Paula-I.; Alarcón, Graciela S. (Springer, 2016)
    Treat to target (T2T) strategies have proved to be useful in several chronic disorders, including Rheumatoid Arthritis. In systemic lupus erythematosus (SLE), T2T strategy has been proposed in order to control disease ...
  • González, L.A.; Pons-Estel, G.J.; Toloza, S.M.A.; Ugarte Gil, Manuel Francisco; Alarcón, Graciela S. (Elsevier, 2021)
    The Lupus in Minorities: Nature Vs Nurture (LUMINA) cohort has placed Hispanics on the lupus map in the United States. Texan Hispanic and African American patients experience, overall, worse outcomes than the Caucasian and ...

Buscar en el Repositorio


Listar

Panel de Control